Overview
of the global membrane technology market in pharmaceutical,
biopharmaceutical, and life sciences industries
According
to the report, the global market for membrane technology in
pharmaceutical, biopharmaceutical, and life sciences industries is
set to grow from a market value of US$6,461.3 million in 2013 to
US$10,886 million by 2019 by registering a CAGR of 9.1% between 2014
and 2019.
The
membrane technology market for pharmaceutical, biopharmaceutical, and
life sciences industries has grown in recent times owing to the
global rise in pharmaceutical production, the adoption of single-use
disposable technique for biopharmaceutical applications, enforcement
of stringent regulations, and focus on product modification and
product innovation.
On
the flip side, the limitations associated with membrane materials,
need for major capital investments, sky-high operational costs, and
the adverse effects of membrane fouling have threatened to hamper the
growth of the membrane technology market in pharmaceutical,
biopharmaceutical, and life sciences industries.
Browse
Market Research
Report:
http://www.transparencymarketresearch.com/membrane-technology-market.html
http://www.transparencymarketresearch.com/membrane-technology-market.html
Companies
mentioned in the research report
Some
of the leading players in the membrane technology market in
pharmaceutical, biopharmaceutical, and life sciences industries are
Merck Millipore, Sartorius, Advantec MFS, Amazon Filters, Trisep
Corporation, GE Healthcare Life Sciences, Pall Corporation, Koch
Membrane System, Novasep, and 3M Company. Among these, GE Healthcare
and 3M Healthcare have been dominating the global market over the
years.
The
research report profiles each of these companies on the basis of
attributes such as recent developments, company and financial
overview, sustainability, and growth strategies.
Fill
the form for an exclusive sample of this report:
No comments:
Post a Comment